Anxiety disorders
Anxiety disorders are chronic,1 highly impairing2–4 and associated with the development of comorbid mood and substance use disorders.5–7 Individuals with anxiety disorders rarely seek treatment (approximately one in five individuals with an anxiety disorder seek treatment in both the USA and China)8 9 and responses to current treatments are modest at best.10 11 The estimated cost of anxiety disorders in America alone is over US$45 billion.12 13 Given this substantial societal burden of anxiety disorders, more work is needed to prevent and treat these devastating diseases. Understanding the neurobiology of risk for anxiety disorders is a critical first step.
Behavioural inhibition
Anxiety disorders are often preceded by behavioural inhibition,14–17 the tendency to be shy, cautious and avoidant of novelty.18 This temperament begins in infancy as high reactivity to novelty. Infants who are highly reactive to novel stimuli and distressed on separation from their mothers typically become behaviourally inhibited children.18–20 Behavioural inhibition represents the most extreme 15% on a continuum of reactivity to novelty and many, but not all, children with behavioural inhibition develop anxiety disorders later in life.15 Behaviourally inhibited children most commonly develop social anxiety disorder; one meta-analysis found that 43% of behaviourally inhibited children develop social anxiety disorder by late childhood or early adolescence.15 However, childhood behavioural inhibition also increases risk for other anxiety disorders, including generalised anxiety disorder,21 22 phobias,22–24 and agoraphobia.23 Childhood behavioural inhibition also increases risk for a number of other known comorbidities of anxiety disorders, including depression22 25–27 and substance use disorders.28 29
Behavioural inhibition can be observed across cultures30 31 and is evolutionarily conserved across species, including earthworms, octopuses, non-human primates and others (for a review, see Gosling and John32). Additionally, behavioural inhibition is heritable33 34 and has moderate stability across the lifetime;18 35 taken together, these data suggest that behavioural inhibition has a biological basis. Because behavioural inhibition precedes the onset of anxiety disorders, has a known biological basis and is measurable, understanding the neurobiology of behavioural inhibition may allow us to gain traction on the prevention and treatment of anxiety disorders.
In 1988, Dr Jerome Kagan proposed that the biological bases of behavioural inhibition were hyperactivity of the amygdala and hyper-reactivity of the sympathetic nervous system; these changes led to increased reactivity to novelty.36 Physiological studies in children with behavioural inhibition have shown that behavioural inhibition is associated with decreased threshold for activation of the sympathetic nervous system,37 less parasympathetic input, as measured by a higher and more stable (less variable) heart rate,36 38–40 and an increased sympathetic response, as measured by increased heart rate reactivity to stressors,36 41 larger pupillary diameter, increased laryngeal muscle tension, and increased urinary norepinephrine concentration.36 39 Cortisol and related hormones (ie, corticotropin-releasing hormone (CRH)) modulate these stress responses (both initiation of the stress response and inhibition through a negative feedback pathway)42 and much of the early research into the biological basis of behavioural inhibition focused on the cortisol response.
Several studies of the hypothalamic-pituitary-adrenal (HPA) axis response in behavioural inhibition have found that behavioural inhibition is associated with higher cortisol concentrations at baseline and in response to stress. Inhibited children had significantly higher cortisol concentrations at home and in the laboratory39 41 43. Pérez-Edgar et al44 found that behavioural inhibition was associated with higher morning salivary cortisol and that increased cortisol concentration and increased negative affect predicted more social withdrawal behaviour, a precursor of social anxiety. Further investigation showed that increased cortisol concentration in children aged 4 years was significantly associated with increased social withdrawal behaviour, specifically in boys with a history of high negative affect. High cortisol might sustain negative affect and behavioural inhibition in boys with high negative affect early in life. Children with behavioural inhibition may be more sensitive to social stressors, resulting in increased cortisol reactivity—this increased sensitivity to social stressors may be governed by alterations in amygdala, hippocampus and bed nucleus of the stria terminalis (BNST) response.42
Another consistent finding in individuals with behavioural inhibition is increased startle reactivity. In response to a sudden and intense stimulus, humans and lower mammals display a sudden eyeblink response.45 Infants who were highly reactive to novelty had an increase in startle amplitude when a stranger approached.43 Children with behavioural inhibition have a shorter latency to startle response46; children with behavioural inhibition who had a larger startle response during safety developed more internalising problems and social anxiety 2 years later.47 Adolescents with behavioural inhibition who met criteria for an anxiety disorder had heightened startle to safety cues compared with behaviourally inhibited adolescents without an anxiety disorder, but there were no group differences in startle to fear cues.48 Additionally, Schmidt et al found no temperament differences in magnitude of fear-potentiated startle in young children.41 These findings suggest that children with behavioural inhibition have elevated startle to safety, but not fear cues, and that heightened startle to safety cues may predict risk for the development of anxiety disorders. Fear-potentiated startle (ie, increased startle after seeing a fearful stimulus) is thought to be mediated by the amygdala, whereas anxiety-potentiated startle (ie, increased startle in a context that might be associated with threat) is thought to be mediated by the BNST.49 While safety cues signal the lack of threat in these paradigms, behaviourally inhibited children may interpret the entire startle paradigm as anxiety-provoking and thus have elevated startle to safety cues mediated by BNST activation; however, that hypothesis has yet to be tested at this time. Consistent findings of elevated startle to safety cues in behavioural inhibition suggest that BNST function might be altered in behavioural inhibition.
Neurobiology of behavioural inhibition
A number of recent manuscripts have reviewed the neurobiological underpinnings of behavioural inhibition.50–52 Inhibited temperament was initially described as the tendency to avoid and be wary of novel people, places or things. As the amygdala responds to novel, fearful and salient stimuli in the environment53 54 and has efferent projections to the limbic system, sensory cortex, and brainstem,53–56 amygdala hyperactivity was first proposed as the neurobiological basis of inhibited temperament.39 57
Early neuroimaging studies found that behavioural inhibition was associated with a faster,58 larger50 59 and more sustained58 amygdala response to novel social stimuli. Behavioural inhibition was also associated with increased amygdala response to newly familiar social stimuli60 61 and internal reflection about social stimuli.62 Consistent with evidence in rodents that sustained stress and increased cortisol activity leads to larger amygdala volume,63–65 amygdala volume and activation are increased in young adults with behavioural inhibition.66 Despite evidence for amygdala hyperactivity in behavioural inhibition, identifying these changes in amygdala function and structure has not led to differences in treatment or prevention of anxiety disorders. Failure of amygdala findings to lead to changes in prevention or treatment suggests that we should search for additional neurobiological markers of behavioural inhibition.